Redefining Hidradenitis Suppurativa Treatment: Integrating Hypochlorous Acid and Ovine Forestomach Matrix Grafts for Enhanced Outcomes (1.0 CEU)

60 min
Thursday, July 10, 2025
1:30 PM - 2:30 PM
Supported by an education grant from Aroa Biosurgery and Urgo Medical North America.

Learning Objectives:
• Explore current treatment options aimed at managing HS symptoms, reducing flare-ups, and improving patient quality of life.
• Examine the science behind hypochlorous acid preserved wound cleanser and its potential benefits in managing hidradenitis suppurativa (HS) by removal of germs and necrotic debris mechanically.
• Describe surgical intervention for hidradenitis suppurativa (HS) and the role of engineered extracellular matrix (ECM) in soft tissue repair, including how ECM-based therapies like Ovine Forestomach Matrix Grafts promote healing, tissue regeneration, and reduce HS lesion recurrence.
• Explore clinical cases illustrating an algorithmic approach for managing hidradenitis suppurativa (HS) with Ovine Forestomach Matrix Grafts and hypochlorous acid-preserved wound cleansers.
share
Back to top